At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
SmartMouth Advanced Clinical Formula Clinical Research Design Protocol
In Brief
A clinical study evaluating SmartMouth Clinical DDS mouthrinse, 0.12% chlorhexidine rinse, and 1 other intervention for Gingivitis and Periodontitis. Completed, enrolled 80 participants across 2 sites.
Detailed Summary
The aim of this study is to provide evidence on the clinical efficacy of SmartMouth Advanced Clinical Formula mouthrinse in comparison to the efficacy of 0.12% chlorhexidine mouthrinse and a placebo mouthrinse. The placebo will be provided by the sponsor and will be identical to SmartMouth ACF (Advanced Clinical Formula), except it will not contain cetylpyridinium chloride, zinc chloride and sodium chlorite. The primary outcomes include measures of plaque and gingivitis. Secondary outcomes include evaluation of tooth discoloration, taste perception, malodor and calculus.
Study Details
Timeline
Interventions
Subjects use SmartMouth Clinical DDS mouth rinse for six weeks.
Subjects use chlorhexidine mouth rinse for six weeks.
Subjects use placebo mouth rinse for six weeks. The placebo rinse is the same as SmartMouth Clinical DDS, but without the active ingredients.